Carter Eric G

CIK 00013876604 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001387660

Recent Transactions

45 trades

Award
AEON Biopharma, Inc.$AEON
Class A Common Stock
2026-06-17+222,684→ 258,705 total
Award
AEON Biopharma, Inc.$AEON
Restricted Stock Units
2025-05-21+308,641→ 308,641 total
Award
AEON Biopharma, Inc.$AEON
Class A Common Stock
2024-08-31+36,021→ 36,021 total
Award
AEON Biopharma, Inc.$AEON
Stock Option
2024-08-31+96,210→ 96,210 total
Award
AEON Biopharma, Inc.$AEON
Stock Option
2024-03-19+16,260→ 16,260 total
Award
AEON Biopharma, Inc.$AEON
Stock Option
2024-03-19+8,130→ 8,130 total
Award
AEON Biopharma, Inc.$AEON
Stock Option
2023-08-14+58,851→ 58,851 total
Award
AEON Biopharma, Inc.$AEON
Stock Option
2023-07-21+9,007→ 9,007 total
Award
AEON Biopharma, Inc.$AEON
Stock Option
2023-07-21+11,802→ 11,802 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-23+30,000→ 30,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2019-07-31+45,000→ 45,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2018-05-31+35,000→ 35,000 total
Award
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2018-04-23+75,000→ 75,000 total
Award
Adverum Biotechnologies, Inc.
Common Stock
2017-09-07+48,000→ 48,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2017-09-07+69,000→ 69,000 total
Disposition to Issuer
KING PHARMACEUTICALS INC
Performance Share Units
2011-01-31−17,860→ 0 total
Disposition to Issuer
KING PHARMACEUTICALS INC
Performance Share Units
2011-01-31−55,740→ 0 total
Disposition from Tender
KING PHARMACEUTICALS INC
Common Stock
2011-01-31−135,427→ 38,740 total
Disposition to Issuer
KING PHARMACEUTICALS INC
Common Stock
2011-01-31−38,740→ 0 total
Other
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-01-31−34,240→ 0 total
Other
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-01-31−42,240→ 0 total
Other
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-01-31−50,290→ 0 total
Award
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2011-01-18+17,860→ 17,860 total
Award
KING PHARMACEUTICALS INC
Common Stock
2011-01-07+16,260→ 174,167 total
Award
KING PHARMACEUTICALS INC
Common Stock
2011-01-07+16,260→ 136,227 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2010-12-31−37,940→ 0 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Common Stock
2010-12-31+37,940→ 174,167 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2010-11-29$14.15/sh−40,426→ 119,967 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2010-03-22$12.25/sh−1,772→ 164,514 total
Award
KING PHARMACEUTICALS INC
Common Stock
2010-03-17+11,970→ 166,286 total
Award
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2010-03-17+42,240→ 42,240 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2010-03-10$12.22/sh−4,121→ 160,393 total
Award
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2010-02-25+55,740→ 55,740 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2010-01-25$12.35/sh−4,523→ 154,316 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2009-12-31−12,698→ 0 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Common Stock
2009-12-31+12,698→ 158,839 total
Award
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2009-03-23+50,290→ 50,290 total
Award
KING PHARMACEUTICALS INC
Common Stock
2009-03-23+15,930→ 146,141 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2009-03-10$6.31/sh−534→ 130,211 total
Award
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2009-02-17+37,940→ 37,940 total
Award
KING PHARMACEUTICALS INC
Common Stock
2009-01-16+1,645→ 130,745 total
Award
KING PHARMACEUTICALS INC
Common Stock
2009-01-16+1,645→ 130,745 total
Award
KING PHARMACEUTICALS INC
Common Stock
2007-11-29+100,000→ 118,260 total
Award
KING PHARMACEUTICALS INC
Common Stock
2007-03-21+5,460→ 18,260 total
Award
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2007-03-21+10,750→ 10,750 total

Companies

Recent Filings

Address

C/O AEON BIOPHARMA, INC. 5 PARK PLAZA, SUITE 1750

IRVINE, CA, 92614

View on SEC.gov